Talquetamab delivers high response rates in refractory myeloma; learn how to prevent skin, nail and oral side effects to stay on therapy. As the therapeutic arsenal for relapsed/refractory multiple ...
FDA approval extends nivolumab into first-line stage III/IV cHL in adults and pediatrics, following priority review of the supplemental application for nivolumab plus AVD. SWOG S1826 showed superior ...
The U.S. Chemical Safety and Hazard Investigation Board (CSB) released an update on the agency’s ongoing investigation into the catastrophic blasts at the Accurate Energetic Systems, LLC (AES) ...
Broadcom Inc. (NASDAQ:AVGO) a global leader that designs, develops and supplies semiconductor and infrastructure software solutions, today announced that it is shipping the world’s first end-to-end ...
Business Insider Africa on MSN
Mali restructures embassies in Russia, China and 5 other nations as it tightens grip on gold sector
Malian leader, Assimi Goïta is accelerating Mali’s diplomatic and economic repositioning as the country expands its global footprint and tightens control over its gold sector, in moves that signal a ...
Concerns rise as BlackRock's purchase of AES Corporation may lead to higher utility bills for Indianapolis residents.
The US Chemical Safety and Hazard Investigation Board (CSB) released on Monday an update on the agency’s ongoing ...
The U.S. Chemical Safety and Hazard Investigation Board (CSB; Washington, D.C.; today released an update on the agency’s ongoing investigation of explosion at manufacturing facility ...
Families of the victims killed in the October AES explosion and their attorneys are still searching for answers.
The U.S. Navy decommissioned its only four minesweepers in the Middle East last year, but still maintains other countermine ...
Zacks Small Cap Research on MSN
NSRX: NS002 phase II topline results
By John Vandermosten, CFA NYSE: NSRX Nasus (NYSE: NSRX) reported topline results from its pharmacokinetic (PK) and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results